Katrine Bosley is having a pretty good year. She was the CEO of Bedford, MA-based Avila Therapeutics when the company was acquired by Celgene for $350 million upfront in January.
OK, six months have gone by since that big event. Did she sip a few mai tais on some Carribbean island, recharge her batteries, and find something else interesting to do in biotech?
That’s one of the questions I have ready for her during today’s Tweetchat at Noon ET/9 am PT. This is part of the weeklong series of live Q&A sessions we at Xconomy are conducting on Twitter during the Biotechnology Industry Organization’s annual convention in Boston. I’ll get the questions started, but this is really a chance for readers/followers on Twitter to quiz a few industry leaders about what’s new and challenging in their worlds. Yesterday, we had Alkermes CEO Richard Pops (@popsalks) and Alnylam Pharmaceuticals CEO John Maraganore (@alnylam) as guests on Twitter chats.
Here’s how to follow the action today. I’ll be sending questions from my Twitter account (@ldtimmerman), and Bosley will be answering from hers (@ksbosley). The searchable hash tag on Twitter to follow the stream of questions and answers in real-time is #xcbiochat. So get your questions ready, and I’ll see you there on Twitter at Noon ET.
